{
  "vaccineInfo": [
    {
      "name": "CoronaVac",
      "manufacturer": "Sinovac Biotech (Hong Kong) Limited",
      "dosages": [
        "Two doses should be administered for primary immunization",
        "The second dose is preferably given 28 days after the first dose",
        "0.5ml per dose"
      ],
      "sideEffects": [
        {
         "level": "Very Common\n(≥10% people)",
         "sideEffect": [
            "Injection site: pain",
            "Headache",
            "Fatigue"
          ]
        },
        {
         "level": "Common\n(1% - 10% people)",
         "sideEffect": [
            "Injection site swelling, pruritus, erythema, induration",
            "Myalgia",
            "Diarrhea",
            "Arthralgia",
            "Cough",
            "Chills",
            "Pruritus",
            "Loss of appetite",
            "Rhinorrhea",
            "Sore throat",
            "Nasal congestion",
            "Abdominal pain"
          ]
        },
        {
         "level": "Uncommon\n(0.1% - 1% people)",
         "sideEffect": [
            "Burn at injection site",
            "Vomit",
            "Hypersensitivity",
            "Abnormal skin and mucosa",
            "Fever",
            "Tremor",
            "Flushing",
            "Edema",
            "Dizziness",
            "Frowsiness"
          ]
        },
        {
         "level": "Rare\n(0.01% - 0.1% people)",
         "sideEffect": [
            "Muscle spasms",
            "Eyelid edema",
            "Nosebleeds",
            "Abdominal distension",
            "Constipation",
            "Hyposmia",
            "Ocular congestion",
            "Hot flashes",
            "Hiccup",
            "Conjunctival congestion"
          ]
        },
        {
         "level": "Very rare\n(<0.01% people)",
         "sideEffect": [
            "Bell's palsy (Observed post-authorization in Hong Kong)"
          ]
        },
        {
         "level": "Serious",
         "sideEffect": [
            "No serious adverse event related to vaccination was identified up to 3 February 2021"
          ]
        }
      ]
    },
    {
      "name": "Comirnaty",
      "manufacturer": "Fosun Pharma in collaboration with the German drug manufacturer BioNTech (BNT162b2 mRNA vaccine)",
      "dosages": [
        "Comirnaty is given after dilution as an injection of 0.3ml into a muscle of your upper arm. ",
        "2 injections, given at least 21 days apart"
      ],
      "sideEffects": [
        {
         "level": "Very Common\n(≥10% people)",
         "sideEffect": [
            "Injection site: pain, swelling",
            "Tiredness",
            "Headache",
            "Muscle pain",
            "Chills",
            "Joint pain",
            "Diarrhea",
            "Fever"
          ]
        },
        {
         "level": "Common\n(1% - 10% people)",
         "sideEffect": [
            "Injection site redness",
            "Nausea",
            "Vomiting"
          ]
        },
        {
         "level": "Uncommon\n(0.1% - 1% people)",
         "sideEffect": [
            "Enlarged lymph nodes",
            "Feeling unwell",
            "Arm pain",
            "Insomnia",
            "Injection site itching",
            "Allergic reactions (e.g. rash, itching)"
          ]
        },
        {
         "level": "Rare\n(0.01% - 0.1% people)",
         "sideEffect": [
            "Temporary one-sided facial drooping",
            "Allergic reactions (e.g. hives, swelling of the face)"
          ]
        },
        {
         "level": "Very rare\n(<0.01% people)",
         "sideEffect": [
            "Severe allergic reaction",
            "Myocarditis or pericarditis which can result in breathlessness, palpitations or chest pain"
          ]
        },
        {
         "level": "Serious",
         "sideEffect": ["N/A"]
        }
      ]
    }
    ]
}